Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 4/20 | 0.41 |
| ▸ | TACR1 | P25103 | 4/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 3/20 | 0.35 |
| ▸ | WNT3 | P56703 | 1/20 | 0.35 |
| ▸ | SFRP1 | Q8N474 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3045594 | 0.82 | CYP3A4 (0.53) | CYP3A4CACNA1BNR1I2HTR2CSLC6A4 | |
| SCHEMBL8371376 | 0.80 | HTR6 (0.34) | CYP3A4CACNA1BNR1I2HTR2CHTR6 | |
| SCHEMBL17942305 | 0.79 | HTR6 (0.50) | CYP3A4CACNA1BNR1I2HTR2CHTR6 | |
| SCHEMBL7787142 | 0.77 | STS (0.59) | CYP3A4CACNA1BNR1I2 | |
| SCHEMBL17948971 | 0.76 | HTR6 (0.47) | CYP3A4CACNA1BNR1I2HTR2CHTR6 | |
| SCHEMBL30833472 | 0.76 | HTR6 (0.47) | CYP3A4CACNA1BNR1I2HTR2CHTR6 | |
| SCHEMBL17949306 | 0.76 | HTR6 (0.47) | CYP3A4CACNA1BNR1I2HTR2CHTR6 | |
| SCHEMBL30833392 | 0.76 | HTR6 (0.47) | CYP3A4CACNA1BNR1I2HTR2CHTR6 | |
| SCHEMBL30833407 | 0.76 | HTR6 (0.47) | CYP3A4CACNA1BNR1I2HTR2CHTR6 | |
| SCHEMBL17949307 | 0.76 | HTR6 (0.47) | CYP3A4CACNA1BNR1I2HTR2CHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234604-A1 | Process for Making Substituted Aryl Sulfone Intermediates | LINGHU XIN | 2010-09-16 | — | — | US | disclosed |
| US-20100234604-A1 | Process for Making Substituted Aryl Sulfone Intermediates | LINGHU XIN | 2010-09-16 | — | — | US | disclosed |
| US-20100234603-A1 | Process for Making Substituted Aryl Sulfone Intermediates | LINGHU XIN | 2010-09-16 | — | — | US | disclosed |
| US-20100234603-A1 | Process for Making Substituted Aryl Sulfone Intermediates | LINGHU XIN | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234604-A1 | Process for Making Substituted Aryl Sulfone Intermediates | SULT1A1, SULT1E1, STS | CYP3A4 70/4885CACNA1B 4731/4885NR1I2 3013/4885 |
| US-20100234603-A1 | Process for Making Substituted Aryl Sulfone Intermediates | SULT1A1, SULT1E1, STS | CYP3A4 70/4885CACNA1B 4731/4885NR1I2 3013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.